医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
SEPN · Septerna, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Septerna, Inc.（SEPN）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $72.6M；高管董事有效买入 —、有效卖出 $63.5M。最近申报 2026-10-19。
买入 Bought—
卖出 Sold$72.6M
有效买入 Effective bought—
有效卖出 Effective sold$63.5M
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-15 | Bhatt Elizabeth President and COO | 卖出 Sell | 4,000 | $37.41 | $150K | SEC |
| 2026-09-01 | Long Daniel D. SVP, Drug Discovery | 卖出 Sell | 3,333 | $37.83 | $126K | SEC |
| 2026-08-12 | RA CAPITAL MANAGEMENT, L.P. 10% Owner, Director | 卖出 Sell · 有效 | 1,493,000 | $42.50 | $63.5M | SEC |
| 2026-08-12 | Third Rock Ventures V, L.P. 10% Owner | 卖出 Sell | 147,200 | $50.27 | $7.4M | SEC |
| 2026-08-11 | Bhatt Elizabeth President and COO | 卖出 Sell | 25,000 | $44.00 | $1.1M | SEC |
| 2026-08-03 | Long Daniel D. SVP, Drug Discovery | 卖出 Sell | 3,334 | $34.47 | $115K | SEC |
| 2026-07-15 | Bhatt Elizabeth President and COO | 卖出 Sell | 4,000 | $33.99 | $136K | SEC |
| 2026-07-01 | Long Daniel D. SVP, Drug Discovery | 卖出 Sell | 3,333 | $34.36 | $115K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-01 | Shaikhly Samira Officer | 12,592 | $493K | 10b5-1 |
| 2026-10-01 | Long Daniel D. Officer | 10,001 | $391K | 10b5-1 |
| 2026-08-12 | RA Capital Healthcare Fund LP affiliate | 746,500 | $36.0M | |
| 2026-08-12 | RA Capital Nexus Fund III, L.P. Affiliate | 746,500 | $36.0M | |
| 2026-08-12 | Third Rock Ventures V, L.P. 10% Stockholder | 147,200 | $7.5M | 10b5-1 |
| 2026-08-11 | Bhatt Elizabeth Officer | 29,000 | $1.1M | 10b5-1 |
| 2026-07-15 | Bhatt Elizabeth Officer | 4,000 | $138K | 10b5-1 |
内部人 Insiders
Bhatt Elizabeth、Long Daniel D.、RA CAPITAL MANAGEMENT, L.P.、Third Rock Ventures V, L.P.